Related Experiment Videos

[Retrospective study of Salmonella gastroenteritis in infants]

C L Sheu1, T C Wu, B T Hwang

  • 1Department of Pediatrics, Veterans General Hospital, Taipei, R.O.C.

Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|October 1, 1990
PubMed
Abstract

Insights

Salmonellosis remains a concern, with increasing ampicillin resistance observed. Young infants under three months are at high risk for severe Salmonella bacteremia and complications, necessitating prompt blood cultures and treatment.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Context:

  • Retrospective analysis of 64 pediatric Salmonellosis cases (1985-1988) at a major hospital.
  • Seasonal peaks observed between May and October.
  • Salmonella group B was the predominant serogroup identified.

Purpose:

  • To analyze trends in pediatric Salmonellosis, including incidence, causative agents, antibiotic susceptibility, and complications.
  • To assess the risk of bacteremia and associated outcomes in young infants.
  • To evaluate antibiotic resistance patterns, particularly to ampicillin.

Summary:

  • A significant decrease in ampicillin susceptibility (75% to 11.7%) was noted over the study period.
  • Ceftriaxone demonstrated high efficacy (98.3% susceptibility).
  • Bacteremia occurred in 23.8% of cases, with higher rates in infants under three months (29.4%).
  • Complications included convulsions, failure to thrive, chronic diarrhea, meningitis, and arthritis; one fatality occurred.
  • Average Salmonella shedding duration was 37.5 days.

Impact:

  • Highlights the rising ampicillin resistance in pediatric Salmonellosis, underscoring the need for updated treatment guidelines.
  • Emphasizes the critical risk of bacteremia and severe complications in infants under three months.
  • Recommends early blood culture and appropriate antibiotic therapy for suspected Salmonellosis in this vulnerable population.

Related Concept Videos